gms | German Medical Science

10th Malaria Meeting

Working party Malaria / Section Antiparasitic Chemotherapy of the Paul-Ehrlich-Society (PEG e.V.) in cooperation with the German Society for Tropical Medicine and International Health (DTG e.V.) and the German Society for Parasitology (DGP e.V.)

09.11. - 10.11.2012, Marburg an der Lahn

Antimalarial resistance in Kilifi: an update

Meeting Abstract

Search Medline for

  • S. Borrmann - Magdeburg University School of Medicine, KEMRI-Wellcome Trust, Kilifi, Kenya
  • CATMAP study team - Magdeburg University School of Medicine, KEMRI-Wellcome Trust, Kilifi, Kenya

10th Malaria Meeting. Marburg, 09.-10.11.2012. Düsseldorf: German Medical Science GMS Publishing House; 2013. Doc12mal02

doi: 10.3205/12mal02, urn:nbn:de:0183-12mal023

Published: January 8, 2013

© 2013 Borrmann et al.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc-nd/3.0/deed.en). You are free: to Share – to copy, distribute and transmit the work, provided the original author and source are credited.


Outline

Text

Drug resistance is a disastrous but unavoidable result of evolution of pathogens in the face of drug pressure. We have embarked on a comprehensive long-term study to identify and track early signs of reduced susceptibility of Plasmodium falciparum to artemisinins. Here we will present an update on both clinical studies and whole-genome scans designed to provide an extensive set of baseline data.